These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 9576415)

  • 1. QT prolongation and Torsades de Pointes associated with clarithromycin.
    Lee KL; Jim MH; Tang SC; Tai YT
    Am J Med; 1998 Apr; 104(4):395-6. PubMed ID: 9576415
    [No Abstract]   [Full Text] [Related]  

  • 2. Clarithromycin-Induced Torsades de Pointes.
    Chang NL; Shah P; Bikkina M; Shamoon F
    Am J Ther; 2016; 23(3):e955-6. PubMed ID: 25057773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clarithromycin induced torsade de pointes.
    Hensey C; Keane D
    Ir J Med Sci; 2008 Mar; 177(1):67-8. PubMed ID: 17618400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clarithromycin-induced torsades de pointes].
    Yamaguchi S; Kaneko Y; Yamagishi T; Ohyama Y; Amano M; Arai M; Nakamura T; Hasegawa A; Kurabayashi M
    Nihon Naika Gakkai Zasshi; 2003 Jan; 92(1):143-5. PubMed ID: 12652715
    [No Abstract]   [Full Text] [Related]  

  • 5. Clarithromycin associated with torsades de pointes.
    Kamochi H; Nii T; Eguchi K; Mori T; Yamamoto A; Shimoda K; Ibaraki K
    Jpn Circ J; 1999 May; 63(5):421-2. PubMed ID: 10943628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Torsades de pointes due to drug interaction between disopyramide and clarithromycin.
    Choudhury L; Grais IM; Passman RS
    Heart Dis; 1999; 1(4):206-7. PubMed ID: 11720625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Torsades de pointes following clarithromycin treatment.
    Gysel M; Vieweg WV; Hasnain M; Hancox JC; Kunanithy V; Baranchuk A
    Expert Rev Cardiovasc Ther; 2013 Nov; 11(11):1485-93. PubMed ID: 24147515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Torsades de pointes ventricular tachycardia induced by clarithromycin and disopyramide in the presence of hypokalemia.
    Hayashi Y; Ikeda U; Hashimoto T; Watanabe T; Mitsuhashi T; Shimada K
    Pacing Clin Electrophysiol; 1999 Apr; 22(4 Pt 1):672-4. PubMed ID: 10234723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Divergent proarrhythmic potential of macrolide antibiotics despite similar QT prolongation: fast phase 3 repolarization prevents early afterdepolarizations and torsade de pointes.
    Milberg P; Eckardt L; Bruns HJ; Biertz J; Ramtin S; Reinsch N; Fleischer D; Kirchhof P; Fabritz L; Breithardt G; Haverkamp W
    J Pharmacol Exp Ther; 2002 Oct; 303(1):218-25. PubMed ID: 12235254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Torsades de pointes in two chronic renal failure patients treated with cisapride and clarithromycin.
    Sekkarie MA
    Am J Kidney Dis; 1997 Sep; 30(3):437-9. PubMed ID: 9292575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. QT prolongation and Torsades de Pointes in patients previously treated with anthracyclines.
    Arbel Y; Swartzon M; Justo D
    Anticancer Drugs; 2007 Apr; 18(4):493-8. PubMed ID: 17351403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Torsades de Pointes after Ondansetron Infusion in 2 Patients.
    Lee DY; Trinh T; Roy SK
    Tex Heart Inst J; 2017 Oct; 44(5):366-369. PubMed ID: 29259513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relations of QTc prolongation on the electrocardiogram to torsades de pointes: definitions and mechanisms.
    Morganroth J
    Am J Cardiol; 1993 Aug; 72(6):10B-13B. PubMed ID: 8256748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simplifying QT prolongation for busy clinicians.
    Grindrod KA; Nagge J
    Can Fam Physician; 2019 Apr; 65(4):268-270. PubMed ID: 30979760
    [No Abstract]   [Full Text] [Related]  

  • 15. Erythromycin-induced polymorphous ventricular tachycardia with normal QT interval.
    Chennareddy SB; Siddique M; Karim MY; Kudesia V
    Am Heart J; 1996 Sep; 132(3):691-4. PubMed ID: 8800045
    [No Abstract]   [Full Text] [Related]  

  • 16. Azithromycin-induced torsade de pointes.
    Huang BH; Wu CH; Hsia CP; Yin Chen C
    Pacing Clin Electrophysiol; 2007 Dec; 30(12):1579-82. PubMed ID: 18070319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. QT interval prolongation and torsades de pointes due to erythromycin lactobionate.
    Oberg KC; Bauman JL
    Pharmacotherapy; 1995; 15(6):687-92. PubMed ID: 8602374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac arrest and electrical storm due to recurrent torsades de pointes caused by concomitant clarithromycin, cotrimoxazole and amiodarone treatment.
    Bienias P; Ciurzyński M; Paczyńska M; Pruszczyk P
    Pol Merkur Lekarski; 2014 Nov; 37(221):285-8. PubMed ID: 25546990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. K201, a multi-channel blocker, inhibits clofilium-induced torsades de pointes and attenuates an increase in repolarization.
    Hasumi H; Matsuda R; Shimamoto K; Hata Y; Kaneko N
    Eur J Pharmacol; 2007 Jan; 555(1):54-60. PubMed ID: 17112502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ciprofloxacin-induced torsade de pointes.
    Flanagan MC; Mitchell ES; Haigney MC
    Int J Cardiol; 2006 Nov; 113(2):239-41. PubMed ID: 16386810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.